Discovery and SAR of 1, 3, 4-thiadiazole derivatives as potent Abl tyrosine kinase inhibitors and cytodifferentiating agents
Bioorganic & medicinal chemistry letters, 2008•Elsevier
A series of substituted benzoylamino-2-[(4-benzyl) thio]-1, 3, 4-thiadiazoles has been
discovered as potent Abl tyrosine kinase inhibitors. Molecular docking simulations on the
Abl tyrosine kinase were conducted in order to rationalize the SAR of the synthesized
inhibitors. The most active compound identified from the enzymatic screening (6a) showed
interesting inhibitory activity on Imatinib-sensitive murine myeloid 3B clone and Bcr-Abl-
independent Imatinib-resistant leukemia cells. Surprisingly, 6a was also proved to act as …
discovered as potent Abl tyrosine kinase inhibitors. Molecular docking simulations on the
Abl tyrosine kinase were conducted in order to rationalize the SAR of the synthesized
inhibitors. The most active compound identified from the enzymatic screening (6a) showed
interesting inhibitory activity on Imatinib-sensitive murine myeloid 3B clone and Bcr-Abl-
independent Imatinib-resistant leukemia cells. Surprisingly, 6a was also proved to act as …
A series of substituted benzoylamino-2-[(4-benzyl)thio]-1,3,4-thiadiazoles has been discovered as potent Abl tyrosine kinase inhibitors. Molecular docking simulations on the Abl tyrosine kinase were conducted in order to rationalize the SAR of the synthesized inhibitors. The most active compound identified from the enzymatic screening (6a) showed interesting inhibitory activity on Imatinib-sensitive murine myeloid 3B clone and Bcr-Abl-independent Imatinib-resistant leukemia cells. Surprisingly, 6a was also proved to act as differentiating inducers in human promyelocytic leukemia cells (HL-60).
Elsevier
以上显示的是最相近的搜索结果。 查看全部搜索结果